An article published in the Journal of Huntington’s Disease explores how LoQus23 is planning to turn a set of compelling observations into drugs for patients, as part of a special issue focusing on somatic instability as a key mechanism underpinning Huntington’s disease. Read “Drugging DNA Damage Repair Pathways for Trinucleotide Repeat Expansion Diseases” in a special […]
We were delighted to be able to attend the Huntington’s Disease Society of America (HDSA) conference virtually. For our presentation, we thought it would be helpful for patients to understand why scientists and clinicians are so excited about the mismatch repair pathway in HD patients and what we are doing about it at LoQus23 Therapeutics. […]
LoQus23 is collaborating with Professor Darren Monckton’s lab at the University of Glasgow to assess novel improvements to the current methods for measuring the level of repeat instability over time. This will enable better understanding of the underlying process and thus enable therapeutics development. https://hdsa.org/hd-research/hd-human-biology-project/vilija-lomeikaite-phd-candidate/
